Training

Chair: Mary Elliott

The PSI Training Committee organises five or six training courses each year. Generally our courses are designed to bring statisticians and statistical programmers working in the pharmaceutical industry up-to-date in a particular subject area. Courses are of one or two days' duration, and our presenters are often from academia with particular expertise in the course topic. We focus on application, but also provide sufficient theory to clarify the concepts behind the techniques. Delegate numbers are limited to 30 or less so that there is plenty of opportunity for questions and discussion.

In addition we work with other professional groups and run an annual training course for statisticians new to the industry.  


For further details or to register for future training courses please click here 

Upcoming Events

PSI ToxSIG Webinar: Combining Sexes

The webinar will provide a general introduction to the topic of combining sexes for statistical analysis in Toxicology. It will also discuss guideline recommendations pertaining to this topic.

PSI Webinar: Risk Based Monitoring & QTL's

Since the introductio of ICH-E6 R2 Addendum sponsors must introduce formal Quality Risk Management and define Quality Tolerance Limits to their clnical development programs. This webinar will cover an introduction to those concepts, recent developments and examples of how companies are defining QTL's in practice.

PSI Webinar: Innovative approaches in the development of pediatric medicines

Do you want to learn more about innovative approaches for the development of pediatric medicines? Then join this PSI webinar on December 8. We have organized an exciting webinar with very knowledgeable speakers who will share their thoughts, ideas and experiences, including case studies, on a range of issues relating to historical data, Bayesian methodology, and partial and full extrapolation approaches in the context of developing pediatric medicines.

PSI Vaccine SIG Webinar: Some considerations on developing COVID-19 Vaccines

Statistical Observations on SARS-CoV-2 & Crisis Vaccine Clinical Testing. Scott Patterson, Bo Fu, Ya Meng, Fabrice Bailleux, Josh Chen.

PSI EIWG Webinar: PIONEERing estimands in Clinical Research

Bringing estimands to life through a real case study. Members of the estimands Implementation Working Group (EIWG) will describe the background and study objectives, intercurrent events of interest and chosen estimands in the PIONEER study.

Latest Jobs

Associate Director, Biostatistics

Discover your extraordinary potential by working as a Covance AD, Biostatistics / Senior Principal Biostatistician. You will consult in the design of complex and innovative studies & clinical trial programs as well as Leading DMC/DSMB processes.

Senior Principal / Principal Biostatistician

Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.

Senior Principal / Principal Biostatistician (Oncology) – FSP

Join our team as a Covance FSP Senior Principal or Principal Biostatistician. You will be assigned to one Sponsor working on Phase I and II oncology studies. Previous Lead experience essential. Office or home-based anywhere in Europe or South Africa.

Statistician for early clinical trials in BioPharmaceuticals R&D

Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, decision making, analytics and interpretation.